financetom
Business
financetom
/
Business
/
Research Alert: Fy Results Show Steady Growth Heading Into Buyout; CFRA Maintains Hold Opinion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: Fy Results Show Steady Growth Heading Into Buyout; CFRA Maintains Hold Opinion
Nov 3, 2025 3:36 PM

06:15 PM EST, 11/03/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain our Hold rating after the acquisition announcement. The transaction represents a 46% premium and $18.3B enterprise value. We believe HOLX fits private equity well given its market leadership, predictable cash flows, defensive health care exposure, and growth opportunities benefiting from operational improvements. The acquisition is expected to close in the first half of 2026 with ADIA and GIC minority investments. We raised our 12-month target price to $79 from $58 on October 21. Our target price is entirely dependent on the private equity takeover announced in October 2025. HOLX agreed to be acquired by Blackstone (BX 144 *****) and TPG (TPG 55 NR) for $76 per share in cash plus a contingent value right of up to $3 per share, totaling up to $79 per share.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SpringWorks Therapeutics Insider Sold Shares Worth $1,617,329, According to a Recent SEC Filing
SpringWorks Therapeutics Insider Sold Shares Worth $1,617,329, According to a Recent SEC Filing
Feb 13, 2025
04:11 AM EST, 02/13/2025 (MT Newswires) -- Daniel Pichl, Chief People Officer, on February 10, 2025, sold 29,750 shares in SpringWorks Therapeutics ( SWTX ) for $1,617,329. Following the Form 4 filing with the SEC, Pichl has control over a total of 50,762 common shares of the company, with 50,762 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773427/000110465925012365/xslF345X05/tm256428-5_4seq1.xml ...
Ascendis Pharma Allocates $25 Million for Share Repurchases, Net Settlement of RSUs
Ascendis Pharma Allocates $25 Million for Share Repurchases, Net Settlement of RSUs
Feb 13, 2025
04:09 AM EST, 02/13/2025 (MT Newswires) -- Ascendis Pharma ( ASND ) said late Wednesday its board has allocated $25 million to fund a share buyback program and the net settlement of certain restricted stock units, or RSUs. The buyback program authorizes the repurchase from time to time of up to about $18.3 million of American depositary shares. The company...
Super Micro Computer Prices Private Placement of $700 Million in Convertible Senior Notes
Super Micro Computer Prices Private Placement of $700 Million in Convertible Senior Notes
Feb 13, 2025
04:08 AM EST, 02/13/2025 (MT Newswires) -- Super Micro Computer ( SMCI ) said late Wednesday it has priced its private placement of $700 million in 2.25% convertible senior notes due 2028. The company said it also amended pricing terms for its existing private placement of $1.73 billion convertible senior notes due 2029. The amendments and subscription are expected to...
Meta Platforms Insider Sold Shares Worth $14,111,832, According to a Recent SEC Filing
Meta Platforms Insider Sold Shares Worth $14,111,832, According to a Recent SEC Filing
Feb 13, 2025
04:08 AM EST, 02/13/2025 (MT Newswires) -- Mark Zuckerberg, 10% Owner, Director, Chair of Board and Chief Executive Officer, on February 11, 2025, sold 19,668 shares in Meta Platforms ( META ) for $14,111,832. Following the Form 4 filing with the SEC, Zuckerberg has control over a total of 141,000 Class A common shares of the company, with 141,000 controlled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved